Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose PEG with or without Sena grafin for bowel preparation in chronic kidney disease
IRCT20180412039283N2Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Mar 2021
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, double-blind trial of macrogol and sennosides in chronic kidney disease (CKD) (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: Blood urea nitrogen, Serum creatinine and 3 more. Started Mar 2021; status: completed.
02
Drugs
macrogolsennosides
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on IRCT20180412039283N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180412039283N2.